Humanigen analyst ratings
Humanigen analyst ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
07/13/2022 | — | HC Wainwright & Co. | Downgrades | Buy → Neutral | |
09/10/2021 | 201% | Jefferies | $37 → $9 | Downgrades | Buy → Hold |
09/09/2021 | — | JP Morgan | Downgrades | Neutral → Underweight | |
09/09/2021 | 836.45% | HC Wainwright & Co. | $36 → $28 | Maintains | Buy |
08/13/2021 | 702.68% | Credit Suisse | $25 → $24 | Maintains | Outperform |
08/10/2021 | 970.23% | Roth Capital | $37 → $32 | Maintains | Buy |
06/11/2021 | 836.45% | Credit Suisse | → $28 | Initiates Coverage On | → Outperform |
05/07/2021 | 903.34% | Oppenheimer | → $30 | Initiates Coverage On | → Outperform |
04/12/2021 | 1104.01% | HC Wainwright & Co. | $34 → $36 | Reiterates | → Buy |
12/23/2020 | 1070.57% | National Securities Corporation | → $35 | Initiates Coverage On | → Buy |
12/22/2020 | 803.01% | Jefferies | → $27 | Initiates Coverage On | → Buy |
10/21/2020 | 736.12% | Cantor Fitzgerald | → $25 | Initiates Coverage On | → Overweight |
10/14/2020 | 936.79% | HC Wainwright & Co. | → $31 | Initiates Coverage On | → Buy |
10/01/2020 | 736.12% | Roth Capital | → $25 | Initiates Coverage On | → Buy |
日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
---|---|---|---|---|---|
07/13/2022 | — | HC Wainwright & Co. | 降级 | 买入 → 中性 | |
2021 年 10 月 9 日 | 201% | 杰富瑞集团 | 37 美元 → 9 美元 | 降级 | 买入 → 持有 |
2021 年 9 月 9 日 | — | 摩根大通 | 降级 | 中性 → 体重不足 | |
2021 年 9 月 9 日 | 836.45% | HC Wainwright & Co. | 36 美元 → 28 美元 | 维护 | 买 |
08/13/2021 | 702.68% | 瑞士信贷 | 25 美元 → 24 美元 | 维护 | 跑赢大盘 |
08/10/2021 | 970.23% | 罗斯资本 | 37 美元 → 32 美元 | 维护 | 买 |
06/11/2021 | 836.45% | 瑞士信贷 | → 28 美元 | 启动覆盖范围开启 | → 跑赢大盘 |
05/07/2021 | 903.34% | 奥本海默 | → 30 美元 | 启动覆盖范围开启 | → 跑赢大盘 |
2021 年 12 月 4 日 | 1104.01% | HC Wainwright & Co. | 34 美元 → 36 美元 | 重申 | → 购买 |
12/23/2020 | 1070.57% | 国家证券公司 | → 35 美元 | 启动覆盖范围开启 | → 购买 |
12/22/2020 | 803.01% | 杰富瑞集团 | → 27 美元 | 启动覆盖范围开启 | → 购买 |
10/21/2020 | 736.12% | 坎托·菲茨杰拉德 | → 25 美元 | 启动覆盖范围开启 | → 超重 |
2020 年 10 月 14 日 | 936.79% | HC Wainwright & Co. | → 31 美元 | 启动覆盖范围开启 | → 购买 |
2020 年 1 月 10 日 | 736.12% | 罗斯资本 | → 25 美元 | 启动覆盖范围开启 | → 购买 |
Humanigen Questions & Answers
Humanigen 问题与解答
The latest price target for Humanigen (NASDAQ: HGEN) was reported by HC Wainwright & Co. on July 13, 2022. The analyst firm set a price target for $0.00 expecting HGEN to fall to within 12 months (a possible -100.00% downside). 6 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 于2022年7月13日公布了Humanigen(纳斯达克股票代码:HGEN)的最新目标股价。该分析公司将目标股价定为0.00美元,预计HGEN将在12个月内跌至-100.00%(可能下跌100.00%)。去年有6家分析公司公布了评级。
The latest analyst rating for Humanigen (NASDAQ: HGEN) was provided by HC Wainwright & Co., and Humanigen downgraded their neutral rating.
HC Wainwright & Co. 对Humanigen(纳斯达克股票代码:HGEN)的最新分析师评级由HC Wainwright & Co. 提供,Humanigen下调了中性评级。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Humanigen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Humanigen was filed on July 13, 2022 so you should expect the next rating to be made available sometime around July 13, 2023.
分析师在进行了广泛的研究后得出了股票评级,其中包括浏览公开财务报表,与Humanigen的高管和客户交谈,以及听取财报电话会议。大多数分析师每三个月做一次这样的评级,因此每家公司每年应该获得4次评级。Humanigen的最新评级是在2022年7月13日发布的,因此您应该预计下一个评级将在2023年7月13日左右公布。
While ratings are subjective and will change, the latest Humanigen (HGEN) rating was a downgraded with a price target of $0.00 to $0.00. The current price Humanigen (HGEN) is trading at is $2.99, which is out of the analyst's predicted range.
尽管评级是主观的,并且会发生变化,但最新的Humanigen(HGEN)评级已下调,目标股价为0.00美元至0.00美元。Humanigen(HGEN)目前的交易价格为2.99美元,超出了分析师的预期区间。